Sandoz Group AG | WebDisclosure

Switch to English

9698	Sociétés
193291	Mots-clés
124576	Articles
102918	Communiqués

Accueil
Sociétés
Sandoz Group AG

COMMUNIQUÉ DE PRESSE

publié le 12/11/2025 à 07:35, il y a 2 mois 8 jours

Sandoz signs global license agreement to commercialize breast cancer biosimilar pertuzumab
Sandoz signs global license agreement with EirGenix Inc. to commercialize biosimilar pertuzumab for HER2-positive breast cancer treatment, reinforcing its position in oncology

Agreement Biosimilar Breast Cancer Sandoz Pertuzumab
BRÈVE

publiée le 04/11/2025 à 22:10, il y a 2 mois 15 jours

Sandoz Acquires Just-Evotec Biologics to Expand Biosimilars Capabilities

Acquisition Biosimilars Toulouse Sandoz Just-Evotec
BRÈVE

publiée le 04/11/2025 à 22:10, il y a 2 mois 15 jours

Sandoz acquiert Just-Evotec Biologics pour développer ses capacités dans le domaine des biosimilaires.

Acquisition Biosimilaires Toulouse Sandoz Just-Evotec
COMMUNIQUÉ DE PRESSE

publié le 04/11/2025 à 22:05, il y a 2 mois 15 jours

Sandoz boosts in-house biosimilars capabilities by signing agreement to acquire Just-Evotec Biologics EU SAS in Toulouse
Sandoz strengthens biosimilars capabilities with acquisition of Just-Evotec Biologics EU SAS in Toulouse. Acquisition aims to capture projected biosimilar market opportunity. Transaction includes cash payment and technology license fees

Acquisition Biosimilars Sandoz Just-Evotec Biologics Continuous Manufacturing Technology
BRÈVE

publiée le 30/10/2025 à 07:05, il y a 2 mois 21 jours

Sandoz annonce une croissance de ses ventes et une révision à la hausse de ses prévisions de marge.

Croissance Des Ventes Biosimilaires Performance Régionale Orientation Financière Questions Commerciales
BRÈVE

publiée le 30/10/2025 à 07:05, il y a 2 mois 21 jours

Sandoz Reports Growth in Sales and Upgraded Margin Guidance

Financial Guidance Sales Growth Biosimilars Regional Performance Trade Issues
COMMUNIQUÉ DE PRESSE

publié le 30/10/2025 à 07:00, il y a 2 mois 21 jours

Sandoz delivers a further acceleration in sales growth; full-year margin guidance upgraded
Sandoz reports 5% growth in net sales for 9 months, with biosimilars contributing over 30%. Full-year margin guidance raised to 21-22% core EBITDA

EBITDA Net Sales Biosimilars Sandoz Margin Guidance
BRÈVE

publiée le 09/09/2025 à 07:05, il y a 4 mois 11 jours

Sandoz et Regeneron règlent un litige en matière de brevets

Approbation De La FDA Biosimilaire Sandoz Regeneron Aflibercept
BRÈVE

publiée le 09/09/2025 à 07:05, il y a 4 mois 11 jours

Sandoz and Regeneron Resolve Patent Dispute

FDA Approval Biosimilar Sandoz Regeneron Aflibercept
COMMUNIQUÉ DE PRESSE

publié le 09/09/2025 à 07:00, il y a 4 mois 11 jours

Sandoz reaches agreement with Regeneron, resolving all patent litigation related to its US aflibercept biosimilar
Sandoz reaches agreement with Regeneron on patent litigation related to US aflibercept biosimilar, enabling launch of Enzeevu™ by end of 2026. Agreement strengthens Sandoz biosimilar portfolio and expands US market growth strategy

Biosimilar Patent Litigation Sandoz Regeneron Enzeevu

Les Echos

Publié le 20/01/2026 à 07:30, il y a 2 heures 48 minutes

Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling
Publié le 20/01/2026 à 07:30, il y a 2 heures 48 minutes

Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Publié le 20/01/2026 à 07:30, il y a 2 heures 48 minutes

Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Publié le 19/01/2026 à 17:45, il y a 16 heures 33 minutes

Financial communication calendar 2026
Publié le 19/01/2026 à 17:45, il y a 16 heures 33 minutes

Calendrier de communication financière 2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 20/01/2026 à 08:00, il y a 2 heures 18 minutes

Grande Portage Resources Receives Approval for 2026 Plan of Operations (Drill Permit) from the US Forest Service
Publié le 20/01/2026 à 01:10, il y a 9 heures 8 minutes

Kalo Gold Announces Closing of Second and Final Tranche of Life Offering and Concurrent Private Placement for Total Gross Proceeds of $12.45 Million to Advance the Vatu Aurum Project
Publié le 20/01/2026 à 00:35, il y a 9 heures 43 minutes

Kidoz Welcomes France’s Proposed Under-15 Social Media Ban
Publié le 20/01/2026 à 00:00, il y a 10 heures 18 minutes

RE Royalties Announces Annual Grant of Stock Options and Restricted Share Units
Publié le 19/01/2026 à 22:55, il y a 11 heures 23 minutes

Organto Foods Inc. Implements Early Warrant Exercise Incentive Program

Voir tout ACCESSWIRE

EQS Group

Publié le 20/01/2026 à 10:05, il y a 12 minutes

Multilingual AI Voice Agent was launched by Zadarma
Publié le 20/01/2026 à 10:00, il y a 17 minutes

PBS Holding AG expands collaboration with Intershop and migrates to AI-powered cloud platform
Publié le 20/01/2026 à 10:00, il y a 18 minutes

ARTCLINE appoints Peter Llewellyn-Davies as Chairman of the Supervisory Board and accelerates commercialization of innovative sepsis therapy
Publié le 20/01/2026 à 10:00, il y a 18 minutes

smartbax in-licenses lead antibacterial compound targeting Gram-negative infections from Aicuris
Publié le 20/01/2026 à 10:00, il y a 18 minutes

Wyden and Taurus Announce Partnership to Empower Automated Trading-to-Custody Workflows for Regulated Institutions